Literature DB >> 21678088

[Biphosphonate-induced femoral stress fractures : A new problem and knowledge so far - case report].

R Lenz1, M Ellenrieder, R Skripitz, R Bader, C Pautke, W Mittelmeier, T Tischer.   

Abstract

During the last several years the treatment of osteoporosis with bisphosphonates has become accepted as a safe and effective procedure. However, recently there have been increasing numbers of reports of rare complications in the literature. Particularly the occurrence of atypical fractures of the femur has become a focus of interest but the problem is insufficiently known and only rarely addressed in the scientific discussion. The case illustrated here and a survey of the important facts in the recent literature highlight essential aspects of long-term bisphosphonate therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21678088     DOI: 10.1007/s00132-011-1786-6

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  34 in total

Review 1.  Bisphosphonate adverse effects, lessons from large databases.

Authors:  Bo Abrahamsen
Journal:  Curr Opin Rheumatol       Date:  2010-07       Impact factor: 5.006

2.  Reduction in normalized bone elasticity following long-term bisphosphonate treatment as measured by ultrasound critical angle reflectometry.

Authors:  Edmond Richer; Matthew A Lewis; Clarita V Odvina; Miguel A Vazquez; Billy J Smith; Roy D Peterson; John R Poindexter; Peter P Antich; Charles Y C Pak
Journal:  Osteoporos Int       Date:  2005-02-22       Impact factor: 4.507

3.  Bisphosphonates are incorporated into adenine nucleotides by human aminoacyl-tRNA synthetase enzymes.

Authors:  M J Rogers; R J Brown; V Hodkin; G M Blackburn; R G Russell; D J Watts
Journal:  Biochem Biophys Res Commun       Date:  1996-07-25       Impact factor: 3.575

4.  Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females.

Authors:  T E Ciarelli; D P Fyhrie; A M Parfitt
Journal:  Bone       Date:  2003-03       Impact factor: 4.398

5.  Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women.

Authors:  G Y Boivin; P M Chavassieux; A C Santora; J Yates; P J Meunier
Journal:  Bone       Date:  2000-11       Impact factor: 4.398

Review 6.  Atypical fractures of the femur and bisphosphonate therapy: A systematic review of case/case series studies.

Authors:  Andrea Giusti; Neveen A T Hamdy; Socrates E Papapoulos
Journal:  Bone       Date:  2010-05-20       Impact factor: 4.398

7.  Atypical insufficiency fracture of the tibia associated with long-term bisphosphonate therapy.

Authors:  Michael D Breglia; John D Carter
Journal:  J Clin Rheumatol       Date:  2010-03       Impact factor: 3.517

8.  Effects of differences in mineralization on the mechanical properties of bone.

Authors:  J D Currey
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1984-02-13       Impact factor: 6.237

9.  Low-energy femoral shaft fractures associated with alendronate use.

Authors:  Andrew S Neviaser; Joseph M Lane; Brett A Lenart; Folorunsho Edobor-Osula; Dean G Lorich
Journal:  J Orthop Trauma       Date:  2008 May-Jun       Impact factor: 2.512

10.  Bone turnover in bone biopsies of patients with low-energy cortical fractures receiving bisphosphonates: a case series.

Authors:  Reina Armamento-Villareal; Nicola Napoli; Kathryn Diemer; Marcus Watkins; Roberto Civitelli; Steven Teitelbaum; Deborah Novack
Journal:  Calcif Tissue Int       Date:  2009-06-23       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.